Smoldering
inflammation often increases the risk of progression for malignant
tumors and simultaneously matures myeloid dendritic cells (mDCs) for cell-mediated immunity. PolyI:C, a dsRNA analog, is reported to induce
inflammation and potent antitumor immune responses via the
Toll-like receptor 3/Toll-
IL-1 receptor domain-containing adaptor molecule 1 (TICAM-1) and
melanoma differentiation-associated protein 5/IFN-β promoter stimulator 1 (IPS-1) pathways in mDCs to drive activation of natural killer cells and cytotoxic T lymphocytes. Here, we found that i.p. or s.c. injection of polyI:C to
Lewis lung carcinoma tumor-implant mice resulted in
tumor regression by converting
tumor-supporting macrophages (Mfs) to
tumor suppressors. F4/80(+)/Gr1(-) Mfs infiltrating the
tumor respond to polyI:C to rapidly produce inflammatory
cytokines and thereafter accelerate M1 polarization. TNF-α was increased within 1 h in both
tumor and serum upon polyI:C injection into
tumor-bearing mice, followed by
tumor hemorrhagic
necrosis and growth suppression. These
tumor responses were abolished in TNF-α(-/-) mice. Furthermore, F4/80(+) Mfs in
tumors extracted from polyI:C-injected mice sustained
Lewis lung carcinoma cytotoxic activity, and this activity was partly abrogated by anti-TNF-α Ab. Genes for supporting M1 polarization were subsequently up-regulated in the
tumor-infiltrating Mfs. These responses were completely abrogated in TICAM-1(-/-) mice, and unaffected in
myeloid differentiation factor 88(-/-) and IPS-1(-/-) mice. Thus, the TICAM-1 pathway is not only important to mature mDCs for cross-priming and natural killer cell activation in the induction of
tumor immunity, but also critically engaged in
tumor suppression by converting
tumor-supporting Mfs to those with tumoricidal properties.